Generation, Selection, and Face Validation of Items for a New Generic Measure of Quality of Life: The EQ-HWB.


Journal

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
ISSN: 1524-4733
Titre abrégé: Value Health
Pays: United States
ID NLM: 100883818

Informations de publication

Date de publication:
04 2022
Historique:
received: 15 06 2021
revised: 06 12 2021
accepted: 08 12 2021
pubmed: 2 3 2022
medline: 6 4 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

This article aims to describe the generation and selection of items (stage 2) and face validation (stage 3) of a large international (multilingual) project to develop a new generic measure, the EQ-HWB (EQ Health and Wellbeing), for use in economic evaluation across health, social care, and public health to estimate quality-adjusted life-years. Items from commonly used generic, carer, social care, and mental health quality of life measures were mapped onto domains or subdomains identified from a literature review. Potential terms and items were reviewed and refined to ensure coverage of the construct of the domains/subdomain (stage 2). Input on the potential item pool, response options, and recall period was sought from 3 key stakeholder groups. The pool of candidate items was tested in qualitative interviews with potential future users in an international face validation study (stage 3). Stage 2 resulted in the generation of 687 items. Predetermined selection criteria were applied by the research team resulting in 598 items being dropped, leaving 89 items that were reviewed by key stakeholder groups. Face validation (stage 3) tested 97 draft items and 4 response scales. A total of 47 items were retained and 14 were modified, whereas 3 were added to the candidate pool of items. This resulted in a 64-item set. This international multiculture, multilingual study with a common methodology identified many items that performed well across all countries. These were taken to the psychometric testing along with modified and new items for the EQ-HWB.

Identifiants

pubmed: 35227597
pii: S1098-3015(22)00010-9
doi: 10.1016/j.jval.2021.12.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

512-524

Subventions

Organisme : Medical Research Council
ID : 170620
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Jill Carlton (J)

School of Health and Related Research, University of Sheffield, Sheffield, England, UK. Electronic address: j.carlton@sheffield.ac.uk.

Tessa Peasgood (T)

Melbourne School of Population and Global Health, University of Melbourne, Australia.

Clara Mukuria (C)

School of Health and Related Research, University of Sheffield, Sheffield, England, UK.

Janice Connell (J)

School of Health and Related Research, University of Sheffield, Sheffield, England, UK.

John Brazier (J)

School of Health and Related Research, University of Sheffield, Sheffield, England, UK.

Kristina Ludwig (K)

Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany.

Ole Marten (O)

Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany.

Simone Kreimeier (S)

Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany.

Lidia Engel (L)

Deakin Health Economics, School of Health and Social Development, Deakin University, Geelong, Australia.

Maria Belizán (M)

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina.

Zhihao Yang (Z)

Health Services Management Department, Guizhou Medical University, Guiyang, China.

Andrea Monteiro (A)

Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, IL, USA.

Maja Kuharic (M)

Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, IL, USA.

Nan Luo (N)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Brendan Mulhern (B)

Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia.

Wolfgang Greiner (W)

Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany.

Simon Pickard (S)

Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, IL, USA.

Federico Augustovski (F)

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH